nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Gliclazide—VEGFA—lung cancer	0.0104	0.366	CrCbGaD
Tolazamide—Glyburide—ABCC3—lung cancer	0.00692	0.244	CrCbGaD
Tolazamide—Leukopenia—Pemetrexed—lung cancer	0.00641	0.0072	CcSEcCtD
Tolazamide—Hyponatraemia—Vinorelbine—lung cancer	0.00613	0.00689	CcSEcCtD
Tolazamide—Pancytopenia—Vinblastine—lung cancer	0.00603	0.00678	CcSEcCtD
Tolazamide—Pancytopenia—Topotecan—lung cancer	0.00586	0.00658	CcSEcCtD
Tolazamide—Thrombocytopenia—Pemetrexed—lung cancer	0.00572	0.00643	CcSEcCtD
Tolazamide—Thrombocytopenia—Gefitinib—lung cancer	0.00569	0.00639	CcSEcCtD
Tolazamide—Dyspepsia—Crizotinib—lung cancer	0.00563	0.00632	CcSEcCtD
Tolazamide—Eruption—Methotrexate—lung cancer	0.00562	0.00631	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Crizotinib—lung cancer	0.00552	0.0062	CcSEcCtD
Tolazamide—Fatigue—Crizotinib—lung cancer	0.00551	0.00619	CcSEcCtD
Tolazamide—Agranulocytosis—Vinblastine—lung cancer	0.00528	0.00594	CcSEcCtD
Tolazamide—Leukopenia—Teniposide—lung cancer	0.00519	0.00583	CcSEcCtD
Tolazamide—Dyspepsia—Pemetrexed—lung cancer	0.00514	0.00578	CcSEcCtD
Tolazamide—Haemolytic anaemia—Cisplatin—lung cancer	0.00507	0.00569	CcSEcCtD
Tolazamide—Hyponatraemia—Irinotecan—lung cancer	0.00506	0.00568	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00505	0.00567	CcSEcCtD
Tolazamide—Fatigue—Pemetrexed—lung cancer	0.00504	0.00566	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gefitinib—lung cancer	0.00501	0.00563	CcSEcCtD
Tolazamide—Pancytopenia—Vinorelbine—lung cancer	0.00501	0.00563	CcSEcCtD
Tolazamide—Fatigue—Gefitinib—lung cancer	0.00501	0.00563	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—lung cancer	0.00487	0.00547	CcSEcCtD
Tolazamide—Urticaria—Pemetrexed—lung cancer	0.00464	0.00522	CcSEcCtD
Tolazamide—Thrombocytopenia—Teniposide—lung cancer	0.00463	0.00521	CcSEcCtD
Tolazamide—Urticaria—Gefitinib—lung cancer	0.00461	0.00518	CcSEcCtD
Tolazamide—Hyponatraemia—Cisplatin—lung cancer	0.00459	0.00516	CcSEcCtD
Tolazamide—Asthenia—Crizotinib—lung cancer	0.00459	0.00516	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.00451	0.0552	CbGpPWpGaD
Tolazamide—Agranulocytosis—Vinorelbine—lung cancer	0.00439	0.00493	CcSEcCtD
Tolazamide—Abdominal distension—Irinotecan—lung cancer	0.00438	0.00492	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.00437	0.0536	CbGpPWpGaD
Tolazamide—Erythema—Erlotinib—lung cancer	0.00425	0.00478	CcSEcCtD
Tolazamide—Dizziness—Crizotinib—lung cancer	0.00423	0.00475	CcSEcCtD
Tolazamide—Hypoglycaemia—Paclitaxel—lung cancer	0.00421	0.00473	CcSEcCtD
Tolazamide—Asthenia—Pemetrexed—lung cancer	0.00419	0.00471	CcSEcCtD
Tolazamide—Asthenia—Gefitinib—lung cancer	0.00417	0.00468	CcSEcCtD
Tolazamide—Pruritus—Pemetrexed—lung cancer	0.00413	0.00465	CcSEcCtD
Tolazamide—Hyponatraemia—Paclitaxel—lung cancer	0.00412	0.00463	CcSEcCtD
Tolazamide—Pruritus—Gefitinib—lung cancer	0.00411	0.00462	CcSEcCtD
Tolazamide—Ill-defined disorder—Vinblastine—lung cancer	0.00411	0.00461	CcSEcCtD
Tolazamide—Rash—Crizotinib—lung cancer	0.00403	0.00453	CcSEcCtD
Tolazamide—Pancytopenia—Gemcitabine—lung cancer	0.00403	0.00452	CcSEcCtD
Tolazamide—Malaise—Vinblastine—lung cancer	0.00399	0.00448	CcSEcCtD
Tolazamide—Ill-defined disorder—Topotecan—lung cancer	0.00399	0.00448	CcSEcCtD
Tolazamide—Vertigo—Vinblastine—lung cancer	0.00398	0.00447	CcSEcCtD
Tolazamide—Leukopenia—Vinblastine—lung cancer	0.00396	0.00445	CcSEcCtD
Tolazamide—Feeling abnormal—Teniposide—lung cancer	0.0039	0.00438	CcSEcCtD
Tolazamide—Malaise—Topotecan—lung cancer	0.00388	0.00436	CcSEcCtD
Tolazamide—Dizziness—Pemetrexed—lung cancer	0.00386	0.00434	CcSEcCtD
Tolazamide—Leukopenia—Topotecan—lung cancer	0.00385	0.00432	CcSEcCtD
Tolazamide—ABCC8—ABC-family proteins mediated transport—ABCC3—lung cancer	0.00383	0.0469	CbGpPWpGaD
Tolazamide—Nausea—Crizotinib—lung cancer	0.0038	0.00427	CcSEcCtD
Tolazamide—Urticaria—Teniposide—lung cancer	0.00376	0.00423	CcSEcCtD
Tolazamide—Pancytopenia—Cisplatin—lung cancer	0.00375	0.00422	CcSEcCtD
Tolazamide—Discomfort—Vinblastine—lung cancer	0.00372	0.00418	CcSEcCtD
Tolazamide—Rash—Pemetrexed—lung cancer	0.00368	0.00414	CcSEcCtD
Tolazamide—Erythema—Vinorelbine—lung cancer	0.00368	0.00413	CcSEcCtD
Tolazamide—Rash—Gefitinib—lung cancer	0.00366	0.00411	CcSEcCtD
Tolazamide—Discomfort—Topotecan—lung cancer	0.00362	0.00406	CcSEcCtD
Tolazamide—Abdominal distension—Paclitaxel—lung cancer	0.00357	0.00402	CcSEcCtD
Tolazamide—Thrombocytopenia—Vinblastine—lung cancer	0.00354	0.00397	CcSEcCtD
Tolazamide—Agranulocytosis—Gemcitabine—lung cancer	0.00353	0.00396	CcSEcCtD
Tolazamide—Hyponatraemia—Docetaxel—lung cancer	0.0035	0.00393	CcSEcCtD
Tolazamide—Nausea—Pemetrexed—lung cancer	0.00347	0.0039	CcSEcCtD
Tolazamide—Nausea—Gefitinib—lung cancer	0.00345	0.00388	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—lung cancer	0.00344	0.00386	CcSEcCtD
Tolazamide—Thrombocytopenia—Topotecan—lung cancer	0.00344	0.00386	CcSEcCtD
Tolazamide—Ill-defined disorder—Vinorelbine—lung cancer	0.00341	0.00383	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—lung cancer	0.00341	0.00383	CcSEcCtD
Tolazamide—Thrombocytopenia—Erlotinib—lung cancer	0.0034	0.00382	CcSEcCtD
Tolazamide—Asthenia—Teniposide—lung cancer	0.0034	0.00382	CcSEcCtD
Tolazamide—Pancytopenia—Paclitaxel—lung cancer	0.00337	0.00379	CcSEcCtD
Tolazamide—Glyburide—ABCG2—lung cancer	0.00336	0.118	CrCbGaD
Tolazamide—Pruritus—Teniposide—lung cancer	0.00335	0.00376	CcSEcCtD
Tolazamide—Malaise—Vinorelbine—lung cancer	0.00332	0.00373	CcSEcCtD
Tolazamide—Vertigo—Vinorelbine—lung cancer	0.0033	0.00371	CcSEcCtD
Tolazamide—Leukopenia—Vinorelbine—lung cancer	0.00329	0.0037	CcSEcCtD
Tolazamide—Aplastic anaemia—Methotrexate—lung cancer	0.00325	0.00365	CcSEcCtD
Tolazamide—Photosensitivity reaction—Paclitaxel—lung cancer	0.00324	0.00364	CcSEcCtD
Tolazamide—Discomfort—Vinorelbine—lung cancer	0.00309	0.00348	CcSEcCtD
Tolazamide—Dyspepsia—Topotecan—lung cancer	0.00309	0.00347	CcSEcCtD
Tolazamide—Dyspepsia—Erlotinib—lung cancer	0.00306	0.00343	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Topotecan—lung cancer	0.00303	0.0034	CcSEcCtD
Tolazamide—Fatigue—Topotecan—lung cancer	0.00302	0.0034	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—lung cancer	0.00301	0.00339	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Erlotinib—lung cancer	0.003	0.00337	CcSEcCtD
Tolazamide—Fatigue—Erlotinib—lung cancer	0.00299	0.00336	CcSEcCtD
Tolazamide—Rash—Teniposide—lung cancer	0.00298	0.00335	CcSEcCtD
Tolazamide—Feeling abnormal—Vinblastine—lung cancer	0.00298	0.00334	CcSEcCtD
Tolazamide—Headache—Teniposide—lung cancer	0.00297	0.00333	CcSEcCtD
Tolazamide—Erythema—Gemcitabine—lung cancer	0.00295	0.00332	CcSEcCtD
Tolazamide—Thrombocytopenia—Vinorelbine—lung cancer	0.00294	0.0033	CcSEcCtD
Tolazamide—Feeling abnormal—Topotecan—lung cancer	0.00289	0.00325	CcSEcCtD
Tolazamide—Pancytopenia—Docetaxel—lung cancer	0.00286	0.00321	CcSEcCtD
Tolazamide—Ill-defined disorder—Irinotecan—lung cancer	0.00281	0.00316	CcSEcCtD
Tolazamide—Nausea—Teniposide—lung cancer	0.00281	0.00316	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—lung cancer	0.00281	0.00316	CcSEcCtD
Tolazamide—Gliclazide—ALB—lung cancer	0.00279	0.0983	CrCbGaD
Tolazamide—Urticaria—Topotecan—lung cancer	0.00279	0.00313	CcSEcCtD
Tolazamide—Erythema—Cisplatin—lung cancer	0.00275	0.00309	CcSEcCtD
Tolazamide—Ill-defined disorder—Gemcitabine—lung cancer	0.00274	0.00308	CcSEcCtD
Tolazamide—Malaise—Irinotecan—lung cancer	0.00274	0.00307	CcSEcCtD
Tolazamide—Vertigo—Irinotecan—lung cancer	0.00272	0.00306	CcSEcCtD
Tolazamide—Leukopenia—Irinotecan—lung cancer	0.00271	0.00305	CcSEcCtD
Tolazamide—Malaise—Gemcitabine—lung cancer	0.00266	0.00299	CcSEcCtD
Tolazamide—Leukopenia—Gemcitabine—lung cancer	0.00264	0.00297	CcSEcCtD
Tolazamide—Asthenia—Vinblastine—lung cancer	0.00259	0.00291	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00259	0.00291	CcSEcCtD
Tolazamide—Fatigue—Vinorelbine—lung cancer	0.00259	0.00291	CcSEcCtD
Tolazamide—Ill-defined disorder—Cisplatin—lung cancer	0.00256	0.00287	CcSEcCtD
Tolazamide—Discomfort—Irinotecan—lung cancer	0.00255	0.00287	CcSEcCtD
Tolazamide—Asthenia—Topotecan—lung cancer	0.00252	0.00283	CcSEcCtD
Tolazamide—Agranulocytosis—Docetaxel—lung cancer	0.0025	0.00281	CcSEcCtD
Tolazamide—Asthenia—Erlotinib—lung cancer	0.00249	0.0028	CcSEcCtD
Tolazamide—Discomfort—Gemcitabine—lung cancer	0.00249	0.00279	CcSEcCtD
Tolazamide—Malaise—Cisplatin—lung cancer	0.00248	0.00279	CcSEcCtD
Tolazamide—Pruritus—Topotecan—lung cancer	0.00248	0.00279	CcSEcCtD
Tolazamide—Erythema—Paclitaxel—lung cancer	0.00247	0.00278	CcSEcCtD
Tolazamide—Feeling abnormal—Vinorelbine—lung cancer	0.00247	0.00278	CcSEcCtD
Tolazamide—Leukopenia—Cisplatin—lung cancer	0.00246	0.00277	CcSEcCtD
Tolazamide—Pruritus—Erlotinib—lung cancer	0.00246	0.00276	CcSEcCtD
Tolazamide—Thrombocytopenia—Irinotecan—lung cancer	0.00242	0.00272	CcSEcCtD
Tolazamide—Dizziness—Vinblastine—lung cancer	0.00239	0.00268	CcSEcCtD
Tolazamide—Urticaria—Vinorelbine—lung cancer	0.00238	0.00268	CcSEcCtD
Tolazamide—Thrombocytopenia—Gemcitabine—lung cancer	0.00236	0.00265	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—lung cancer	0.00234	0.00263	CcSEcCtD
Tolazamide—Dizziness—Topotecan—lung cancer	0.00232	0.00261	CcSEcCtD
Tolazamide—Discomfort—Cisplatin—lung cancer	0.00232	0.0026	CcSEcCtD
Tolazamide—Dizziness—Erlotinib—lung cancer	0.0023	0.00258	CcSEcCtD
Tolazamide—Ill-defined disorder—Paclitaxel—lung cancer	0.0023	0.00258	CcSEcCtD
Tolazamide—Malaise—Etoposide—lung cancer	0.00228	0.00256	CcSEcCtD
Tolazamide—Vertigo—Etoposide—lung cancer	0.00227	0.00255	CcSEcCtD
Tolazamide—Headache—Vinblastine—lung cancer	0.00226	0.00254	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—GRIK3—lung cancer	0.00226	0.0277	CbGpPWpGaD
Tolazamide—Leukopenia—Etoposide—lung cancer	0.00226	0.00254	CcSEcCtD
Tolazamide—Malaise—Paclitaxel—lung cancer	0.00223	0.00251	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—lung cancer	0.00223	0.0025	CcSEcCtD
Tolazamide—Vertigo—Paclitaxel—lung cancer	0.00222	0.0025	CcSEcCtD
Tolazamide—Leukopenia—Paclitaxel—lung cancer	0.00221	0.00249	CcSEcCtD
Tolazamide—Rash—Topotecan—lung cancer	0.00221	0.00249	CcSEcCtD
Tolazamide—Thrombocytopenia—Cisplatin—lung cancer	0.0022	0.00247	CcSEcCtD
Tolazamide—Headache—Topotecan—lung cancer	0.0022	0.00247	CcSEcCtD
Tolazamide—Rash—Erlotinib—lung cancer	0.00219	0.00246	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—lung cancer	0.00218	0.00245	CcSEcCtD
Tolazamide—Dyspepsia—Irinotecan—lung cancer	0.00218	0.00245	CcSEcCtD
Tolazamide—Headache—Erlotinib—lung cancer	0.00217	0.00244	CcSEcCtD
Tolazamide—Asthenia—Vinorelbine—lung cancer	0.00215	0.00242	CcSEcCtD
Tolazamide—Nausea—Vinblastine—lung cancer	0.00215	0.00241	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Irinotecan—lung cancer	0.00214	0.0024	CcSEcCtD
Tolazamide—Fatigue—Irinotecan—lung cancer	0.00213	0.0024	CcSEcCtD
Tolazamide—Pruritus—Vinorelbine—lung cancer	0.00212	0.00239	CcSEcCtD
Tolazamide—Discomfort—Etoposide—lung cancer	0.00212	0.00238	CcSEcCtD
Tolazamide—Erythema—Docetaxel—lung cancer	0.0021	0.00236	CcSEcCtD
Tolazamide—Nausea—Topotecan—lung cancer	0.00208	0.00234	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00208	0.00234	CcSEcCtD
Tolazamide—Discomfort—Paclitaxel—lung cancer	0.00208	0.00234	CcSEcCtD
Tolazamide—Fatigue—Gemcitabine—lung cancer	0.00208	0.00234	CcSEcCtD
Tolazamide—Chlorpropamide—ABCB1—lung cancer	0.00207	0.073	CrCbGaD
Tolazamide—Nausea—Erlotinib—lung cancer	0.00206	0.00232	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—lung cancer	0.00206	0.00231	CcSEcCtD
Tolazamide—Feeling abnormal—Irinotecan—lung cancer	0.00204	0.00229	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—lung cancer	0.00202	0.00227	CcSEcCtD
Tolazamide—Feeling abnormal—Gemcitabine—lung cancer	0.00199	0.00223	CcSEcCtD
Tolazamide—Dizziness—Vinorelbine—lung cancer	0.00198	0.00223	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—lung cancer	0.00198	0.00222	CcSEcCtD
Tolazamide—Thrombocytopenia—Paclitaxel—lung cancer	0.00198	0.00222	CcSEcCtD
Tolazamide—ABCC8—ABC-family proteins mediated transport—ABCB1—lung cancer	0.00195	0.0239	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.00194	0.00218	CcSEcCtD
Tolazamide—Rash—Vinorelbine—lung cancer	0.00189	0.00213	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—lung cancer	0.00189	0.00212	CcSEcCtD
Tolazamide—ABCC8—Regulation of insulin secretion—GNG11—lung cancer	0.00189	0.0231	CbGpPWpGaD
Tolazamide—Headache—Vinorelbine—lung cancer	0.00188	0.00211	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—lung cancer	0.00188	0.00211	CcSEcCtD
Tolazamide—Feeling abnormal—Cisplatin—lung cancer	0.00185	0.00208	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—CHRNB4—lung cancer	0.00184	0.0226	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—GNG11—lung cancer	0.00183	0.0224	CbGpPWpGaD
Tolazamide—Agranulocytosis—Methotrexate—lung cancer	0.0018	0.00203	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—lung cancer	0.00178	0.002	CcSEcCtD
Tolazamide—Nausea—Vinorelbine—lung cancer	0.00178	0.002	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—lung cancer	0.00178	0.002	CcSEcCtD
Tolazamide—Dyspepsia—Paclitaxel—lung cancer	0.00178	0.002	CcSEcCtD
Tolazamide—Asthenia—Irinotecan—lung cancer	0.00178	0.002	CcSEcCtD
Tolazamide—Fatigue—Etoposide—lung cancer	0.00178	0.00199	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00174	0.00196	CcSEcCtD
Tolazamide—Fatigue—Paclitaxel—lung cancer	0.00174	0.00196	CcSEcCtD
Tolazamide—Asthenia—Gemcitabine—lung cancer	0.00173	0.00194	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—lung cancer	0.00171	0.00193	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—CHRNA5—lung cancer	0.00171	0.021	CbGpPWpGaD
Tolazamide—Pruritus—Gemcitabine—lung cancer	0.00171	0.00192	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—lung cancer	0.0017	0.00191	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—lung cancer	0.00168	0.00188	CcSEcCtD
Tolazamide—Feeling abnormal—Paclitaxel—lung cancer	0.00166	0.00187	CcSEcCtD
Tolazamide—Dizziness—Irinotecan—lung cancer	0.00164	0.00184	CcSEcCtD
Tolazamide—Urticaria—Etoposide—lung cancer	0.00164	0.00184	CcSEcCtD
Tolazamide—Asthenia—Cisplatin—lung cancer	0.00161	0.00181	CcSEcCtD
Tolazamide—Urticaria—Paclitaxel—lung cancer	0.0016	0.0018	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—lung cancer	0.00156	0.00176	CcSEcCtD
Tolazamide—Rash—Irinotecan—lung cancer	0.00156	0.00175	CcSEcCtD
Tolazamide—Headache—Irinotecan—lung cancer	0.00155	0.00174	CcSEcCtD
Tolazamide—KCNJ11—Type II diabetes mellitus—MTOR—lung cancer	0.00155	0.0189	CbGpPWpGaD
Tolazamide—ABCC8—ABC-family proteins mediated transport—APOA1—lung cancer	0.00154	0.0188	CbGpPWpGaD
Tolazamide—Rash—Gemcitabine—lung cancer	0.00152	0.00171	CcSEcCtD
Tolazamide—Erythema—Methotrexate—lung cancer	0.00151	0.0017	CcSEcCtD
Tolazamide—Headache—Gemcitabine—lung cancer	0.00151	0.0017	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—lung cancer	0.00151	0.00169	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—GNG11—lung cancer	0.00149	0.0182	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.00148	0.00166	CcSEcCtD
Tolazamide—Asthenia—Etoposide—lung cancer	0.00148	0.00166	CcSEcCtD
Tolazamide—Fatigue—Docetaxel—lung cancer	0.00148	0.00166	CcSEcCtD
Tolazamide—Nausea—Irinotecan—lung cancer	0.00147	0.00165	CcSEcCtD
Tolazamide—Glyburide—ALB—lung cancer	0.00147	0.0516	CrCbGaD
Tolazamide—Pruritus—Etoposide—lung cancer	0.00146	0.00164	CcSEcCtD
Tolazamide—Asthenia—Paclitaxel—lung cancer	0.00145	0.00163	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—GNG11—lung cancer	0.00144	0.0176	CbGpPWpGaD
Tolazamide—Nausea—Gemcitabine—lung cancer	0.00143	0.00161	CcSEcCtD
Tolazamide—Pruritus—Paclitaxel—lung cancer	0.00143	0.0016	CcSEcCtD
Tolazamide—Rash—Cisplatin—lung cancer	0.00142	0.00159	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—lung cancer	0.00141	0.00158	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—lung cancer	0.0014	0.00158	CcSEcCtD
Tolazamide—Glyburide—ABCB1—lung cancer	0.0014	0.0493	CrCbGaD
Tolazamide—KCNJ1—Neuronal System—CHRNA3—lung cancer	0.0014	0.0171	CbGpPWpGaD
Tolazamide—Malaise—Methotrexate—lung cancer	0.00136	0.00153	CcSEcCtD
Tolazamide—Dizziness—Etoposide—lung cancer	0.00136	0.00153	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—lung cancer	0.00136	0.00153	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—lung cancer	0.00135	0.00152	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—ADCY1—lung cancer	0.00134	0.0164	CbGpPWpGaD
Tolazamide—Dizziness—Paclitaxel—lung cancer	0.00133	0.0015	CcSEcCtD
Tolazamide—Nausea—Cisplatin—lung cancer	0.00133	0.0015	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—GNG11—lung cancer	0.00132	0.0162	CbGpPWpGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.00131	0.016	CbGpPWpGaD
Tolazamide—Erythema—Doxorubicin—lung cancer	0.00131	0.00147	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—PPP2R1B—lung cancer	0.0013	0.0159	CbGpPWpGaD
Tolazamide—Rash—Etoposide—lung cancer	0.0013	0.00146	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—ADCY1—lung cancer	0.0013	0.0159	CbGpPWpGaD
Tolazamide—Headache—Etoposide—lung cancer	0.00129	0.00145	CcSEcCtD
Tolazamide—Rash—Paclitaxel—lung cancer	0.00127	0.00143	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—lung cancer	0.00127	0.00143	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.00127	0.0156	CbGpPWpGaD
Tolazamide—Headache—Paclitaxel—lung cancer	0.00126	0.00142	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—PPP2R1B—lung cancer	0.00126	0.0155	CbGpPWpGaD
Tolazamide—Asthenia—Docetaxel—lung cancer	0.00123	0.00138	CcSEcCtD
Tolazamide—Nausea—Etoposide—lung cancer	0.00122	0.00137	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—lung cancer	0.00121	0.00136	CcSEcCtD
Tolazamide—Pruritus—Docetaxel—lung cancer	0.00121	0.00136	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—lung cancer	0.00121	0.00136	CcSEcCtD
Tolazamide—Nausea—Paclitaxel—lung cancer	0.0012	0.00135	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ADCY1—lung cancer	0.00119	0.0145	CbGpPWpGaD
Tolazamide—Malaise—Doxorubicin—lung cancer	0.00118	0.00133	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—lung cancer	0.00118	0.00132	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—lung cancer	0.00117	0.00132	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—GRIK3—lung cancer	0.00115	0.0141	CbGpPWpGaD
Tolazamide—Dizziness—Docetaxel—lung cancer	0.00113	0.00127	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—GRIK3—lung cancer	0.00112	0.0137	CbGpPWpGaD
Tolazamide—Discomfort—Doxorubicin—lung cancer	0.0011	0.00124	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—lung cancer	0.00109	0.00122	CcSEcCtD
Tolazamide—Rash—Docetaxel—lung cancer	0.00108	0.00121	CcSEcCtD
Tolazamide—Headache—Docetaxel—lung cancer	0.00107	0.0012	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—lung cancer	0.00106	0.0012	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—lung cancer	0.00106	0.00119	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—lung cancer	0.00105	0.00117	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00104	0.0127	CbGpPWpGaD
Tolazamide—Nausea—Docetaxel—lung cancer	0.00102	0.00114	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—lung cancer	0.00102	0.00114	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00101	0.0123	CbGpPWpGaD
Tolazamide—Urticaria—Methotrexate—lung cancer	0.00098	0.0011	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—STK11—lung cancer	0.000952	0.0117	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—CHRNB4—lung cancer	0.000941	0.0115	CbGpPWpGaD
Tolazamide—Dyspepsia—Doxorubicin—lung cancer	0.00094	0.00106	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—STK11—lung cancer	0.000923	0.0113	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000922	0.00104	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—lung cancer	0.000921	0.00103	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—CHRNB4—lung cancer	0.000913	0.0112	CbGpPWpGaD
Tolazamide—Asthenia—Methotrexate—lung cancer	0.000885	0.000994	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000881	0.0108	CbGpPWpGaD
Tolazamide—Feeling abnormal—Doxorubicin—lung cancer	0.00088	0.000989	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—CHRNA5—lung cancer	0.000875	0.0107	CbGpPWpGaD
Tolazamide—Pruritus—Methotrexate—lung cancer	0.000873	0.00098	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—CHRNA5—lung cancer	0.000849	0.0104	CbGpPWpGaD
Tolazamide—Urticaria—Doxorubicin—lung cancer	0.000848	0.000953	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—lung cancer	0.000816	0.000916	CcSEcCtD
Tolazamide—Rash—Methotrexate—lung cancer	0.000778	0.000874	CcSEcCtD
Tolazamide—Headache—Methotrexate—lung cancer	0.000773	0.000868	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—lung cancer	0.000766	0.000861	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—lung cancer	0.000756	0.000849	CcSEcCtD
Tolazamide—Nausea—Methotrexate—lung cancer	0.000733	0.000823	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—CHRNA3—lung cancer	0.000713	0.00874	CbGpPWpGaD
Tolazamide—Dizziness—Doxorubicin—lung cancer	0.000706	0.000793	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—CHRNA3—lung cancer	0.000692	0.00847	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—GNG11—lung cancer	0.000675	0.00826	CbGpPWpGaD
Tolazamide—Rash—Doxorubicin—lung cancer	0.000673	0.000757	CcSEcCtD
Tolazamide—Headache—Doxorubicin—lung cancer	0.000669	0.000752	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000668	0.00818	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—GNG11—lung cancer	0.000654	0.00801	CbGpPWpGaD
Tolazamide—Nausea—Doxorubicin—lung cancer	0.000634	0.000713	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—ADCY1—lung cancer	0.000607	0.00743	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—ADCY1—lung cancer	0.000588	0.0072	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—BRAF—lung cancer	0.000502	0.00615	CbGpPWpGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000456	0.00559	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—COL4A3BP—lung cancer	0.000451	0.00553	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AZIN2—lung cancer	0.000451	0.00553	CbGpPWpGaD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000443	0.00542	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AZIN2—lung cancer	0.000438	0.00536	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—COL4A3BP—lung cancer	0.000438	0.00536	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—MDM2—lung cancer	0.000421	0.00515	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—RAF1—lung cancer	0.000419	0.00513	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.0004	0.0049	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ATP5H—lung cancer	0.000384	0.0047	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ATP5H—lung cancer	0.000372	0.00456	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000363	0.00444	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PLBD1—lung cancer	0.000342	0.00419	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PLBD1—lung cancer	0.000332	0.00406	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000326	0.00399	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000326	0.00399	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD17B10—lung cancer	0.000313	0.00383	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD17B10—lung cancer	0.000303	0.00371	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—TF—lung cancer	0.000303	0.00371	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CKB—lung cancer	0.000291	0.00356	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CKB—lung cancer	0.000282	0.00345	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM2—lung cancer	0.000273	0.00335	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CNDP2—lung cancer	0.000273	0.00335	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTMR3—lung cancer	0.000266	0.00326	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CNDP2—lung cancer	0.000265	0.00325	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM2—lung cancer	0.000265	0.00325	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PGAM1—lung cancer	0.000259	0.00317	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTMR3—lung cancer	0.000258	0.00316	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—BRAF—lung cancer	0.000257	0.00314	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PGAM1—lung cancer	0.000251	0.00308	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—BRAF—lung cancer	0.000249	0.00305	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2A7—lung cancer	0.000247	0.00303	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SDC4—lung cancer	0.000242	0.00296	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2A7—lung cancer	0.00024	0.00294	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SDC4—lung cancer	0.000235	0.00287	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—HRAS—lung cancer	0.000231	0.00283	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—RRM1—lung cancer	0.00022	0.0027	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA3—lung cancer	0.00022	0.0027	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—MDM2—lung cancer	0.000215	0.00263	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—RAF1—lung cancer	0.000214	0.00262	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—RRM1—lung cancer	0.000214	0.00262	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA3—lung cancer	0.000214	0.00262	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—AVP—lung cancer	0.00021	0.00257	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—MDM2—lung cancer	0.000208	0.00255	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—RAF1—lung cancer	0.000208	0.00254	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—B4GALT5—lung cancer	0.000207	0.00254	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000204	0.00249	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA4—lung cancer	0.000202	0.00247	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—B4GALT5—lung cancer	0.000201	0.00246	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA2—lung cancer	0.000196	0.00241	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA4—lung cancer	0.000195	0.00239	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA2—lung cancer	0.00019	0.00233	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA1—lung cancer	0.00019	0.00232	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCC3—lung cancer	0.000187	0.00229	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA1—lung cancer	0.000184	0.00225	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCC3—lung cancer	0.000182	0.00223	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKR1C1—lung cancer	0.000181	0.00222	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UGT1A1—lung cancer	0.000176	0.00216	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKR1C1—lung cancer	0.000176	0.00216	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UGT1A1—lung cancer	0.000171	0.00209	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GNG11—lung cancer	0.00017	0.00208	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GNG11—lung cancer	0.000165	0.00202	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALDOA—lung cancer	0.000162	0.00198	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—APOA1—lung cancer	0.000161	0.00197	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA3—lung cancer	0.000157	0.00192	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALDOA—lung cancer	0.000157	0.00192	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ADCY1—lung cancer	0.000153	0.00187	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCG2—lung cancer	0.000153	0.00187	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA3—lung cancer	0.000152	0.00186	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HPGDS—lung cancer	0.00015	0.00183	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ENO2—lung cancer	0.00015	0.00183	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPP2R1B—lung cancer	0.000149	0.00182	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ADCY1—lung cancer	0.000148	0.00181	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCG2—lung cancer	0.000148	0.00181	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTT1—lung cancer	0.000145	0.00178	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HPGDS—lung cancer	0.000145	0.00178	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ENO2—lung cancer	0.000145	0.00178	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPP2R1B—lung cancer	0.000144	0.00177	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2A6—lung cancer	0.000144	0.00176	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GCLC—lung cancer	0.000144	0.00176	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTT1—lung cancer	0.000141	0.00173	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GCLC—lung cancer	0.000139	0.00171	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2A6—lung cancer	0.000139	0.00171	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ENO1—lung cancer	0.000136	0.00167	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000136	0.00167	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ENO1—lung cancer	0.000132	0.00162	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ALB—lung cancer	0.000127	0.00156	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2E1—lung cancer	0.000122	0.0015	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NQO1—lung cancer	0.000121	0.00148	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2E1—lung cancer	0.000118	0.00145	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—HRAS—lung cancer	0.000118	0.00144	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NQO1—lung cancer	0.000117	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—RAF1—lung cancer	0.000115	0.00141	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—HRAS—lung cancer	0.000114	0.0014	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—STK11—lung cancer	0.000109	0.00133	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—STK11—lung cancer	0.000106	0.00129	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTP1—lung cancer	0.000101	0.00123	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CAT—lung cancer	9.8e-05	0.0012	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTP1—lung cancer	9.77e-05	0.0012	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCB1—lung cancer	9.53e-05	0.00117	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CAT—lung cancer	9.5e-05	0.00116	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TYMS—lung cancer	9.36e-05	0.00115	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM1—lung cancer	9.25e-05	0.00113	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCB1—lung cancer	9.24e-05	0.00113	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TYMS—lung cancer	9.08e-05	0.00111	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM1—lung cancer	8.97e-05	0.0011	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1A1—lung cancer	8.77e-05	0.00107	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ERCC2—lung cancer	8.7e-05	0.00107	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1A1—lung cancer	8.51e-05	0.00104	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ERCC2—lung cancer	8.44e-05	0.00103	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—APOA1—lung cancer	7.53e-05	0.000922	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—APOA1—lung cancer	7.3e-05	0.000894	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CG—lung cancer	6.87e-05	0.000842	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CG—lung cancer	6.66e-05	0.000816	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—POMC—lung cancer	6.54e-05	0.000801	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CREBBP—lung cancer	6.37e-05	0.00078	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—POMC—lung cancer	6.34e-05	0.000777	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CREBBP—lung cancer	6.18e-05	0.000757	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CD—lung cancer	6.04e-05	0.00074	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALB—lung cancer	5.96e-05	0.00073	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CD—lung cancer	5.86e-05	0.000717	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALB—lung cancer	5.78e-05	0.000708	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CB—lung cancer	5.27e-05	0.000645	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGS2—lung cancer	5.22e-05	0.000639	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CB—lung cancer	5.11e-05	0.000625	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTGS2—lung cancer	5.06e-05	0.00062	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTEN—lung cancer	4.55e-05	0.000557	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTEN—lung cancer	4.41e-05	0.00054	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—EP300—lung cancer	4.34e-05	0.000531	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—EP300—lung cancer	4.21e-05	0.000515	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CA—lung cancer	3.21e-05	0.000393	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CA—lung cancer	3.11e-05	0.000381	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKT1—lung cancer	2.62e-05	0.000321	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKT1—lung cancer	2.54e-05	0.000311	CbGpPWpGaD
